This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Microsoft, Walmart, Amgen, salesforce.com and Mondelez International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Walmart, Amgen, salesforce.com and Mondelez International
Procter & Gamble Rewards Investors Amid Coronavirus Despair
by Zacks Equity Research
Although U.S. companies are reeling under the uncertain impacts of the coronavirus, Procter & Gamble's (PG) recent move to hike dividend comes as a sigh of relief for investors.
Top Stock Reports for Microsoft, Walmart & Amgen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Walmart (WMT) and Amgen (AMGN).
Mondelez Bolsters Portfolio With Give & Co.'s Inclusion
by Zacks Equity Research
Mondelez (MDLZ) concludes the previously announced buyout of a considerable majority stake in Give & Co.
Philip Morris Suspends Operations at MTB Due to Coronavirus
by Zacks Equity Research
Philip Morris (PM) will suspend all operations at Philip Morris Manufacturing & Technology Bologna S.p.A., Italy, for a week.
Hershey Looks Delectable on Lucrative Buyouts & Strong Brands
by Zacks Equity Research
Hershey (HSY) has been undertaking buyouts to augment the portfolio. Also, its focus on innovation and efforts to enhance operating efficiency bode well.
Mondelez (MDLZ) Gains on Pricing & Buyouts Amid Currency Woes
by Zacks Equity Research
Mondelez (MDLZ) focuses on balancing volumes and profit through disciplined pricing. However, adverse currency movements have been hurting performance.
The Zacks Analyst Blog Highlights: Merck, Novartis, Mondelez International, ServiceNow and General Dynamics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Novartis, Mondelez International, ServiceNow and General Dynamics
Top Analyst Reports for Merck, Novartis & Mondelez
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Novartis (NVS) and Mondelez International (MDLZ).
Mondelez (MDLZ) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Mondelez (MDLZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mondelez's Acquisition Spree Continues With Give & Go's Deal
by Zacks Equity Research
Mondelez's (MDLZ) latest plan to acquire Give & Go is another effort to bolster offerings in the snacks division.
Mondelez's Strategic Plans Underway, Long-Term Goals Intact
by Zacks Equity Research
Mondelez (MDLZ) records solid top and bottom-line growth along with enhanced free cash flow within a year of its strategic plan launch.
Miscellaneous Food Industry Outlook Eclipsed by Rising Costs
by Vrishali Bagree
Food companies have been reeling under cost inflation for various commodities like vegetables, dairy items, as well as animal feed among others.
Why Chocolate? Surprise Your Valentine With Cocoa ETF Instead!
by Sanghamitra Saha
Cocoa ETF feels hotter than chocolate this Valentine's Day.
Here's Why Mondelez (MDLZ) Stock is up 8% After Q4 Results
by Zacks Equity Research
Mondelez (MDLZ) is benefiting from strong organic sales trend. Its solid pricing, focus on innovation and expansion efforts bode well.
Company News for Jan 31, 2020
by Zacks Equity Research
Companies In The News Are: BGG, INO, MDLZ, MGEN
Mondelez's (MDLZ) Stock Up on Q4 Earnings & Revenue Beat
by Zacks Equity Research
Mondelez's (MDLZ) sales grow in fourth-quarter 2019 on the back of pricing and volumes. Management expects adjusted earnings per share to grow in high-single digits for 2020.
Mondelez (MDLZ) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 1.67% and 1.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Mondelez (MDLZ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mondelez (MDLZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Setting the Tone for Mondelez's (MDLZ) Q4 Earnings
by Zacks Equity Research
Benefits from strong brands in the snacking category and strategic buyouts are likely to get reflected in Mondelez's (MDLZ) Q4 performance. However, high costs and adverse currency rates are concerns.
Mondelez Up More Than 40% YTD: Will Growth Sustain in 2020?
by Zacks Equity Research
Mondelez's (MDLZ) efficient pricing, solid innovation, wide emerging market presence and impressive savings plan bode well.
Will Mondelez Sustain Momentum on Solid Pricing & Innovation?
by Zacks Equity Research
Mondelez International (MDLZ) is benefiting from strong organic sales. The company's solid pricing, focus on innovation, and expansion across geographies and multiple platforms bode well.
Why Is Mondelez (MDLZ) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Mondelez (MDLZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These 6 Companies Own All Your Favorite Halloween Candy
by Madeleine Johnson
Halloween is big business for top candy makers, and this year, Americans are projected to spend over $2 billion on Halloween candy.
Mondelez (MDLZ) Lifts View on Q3 Earnings & Revenue Beat
by Zacks Equity Research
Mondelez International (MDLZ) reports better-than-expected earnings and revenues in third-quarter 2019. Also, management raises earnings and organic sales guidance.